Investor Relations

About Vascular and Ultroid Technologies, Inc.

Vascular Technologies, Inc. is a fast-growing medical device company in the United States. Our principal product is the Ultroid® Hemorrhoid Management System, a non-invasive, pain-free, and lower cost treatment than current procedures for the treatment of hemorrhoidal disease (HD).

Shareholder's Meeting

Thank you for your participation in the shareholder conference call that took place Tuesday, May 11, 2010 at 6 p.m. (EDT). Future announcements will be included in this location of the website. Shareholders that were unable to attend the conference call can obtain an audio copy by contacting Michael Knox, CFO, or by requesting a copy through email by sending your request to info@ultroid.com.

For more information about investing in Ultroid Technologies, Inc. and Vascular Technologies, Inc., please contact our Investor Relations Team: investorrelations@ultroid.com.